NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
32 hedge funds and large institutions have $1.26M invested in NexImmune, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 31 → 32 (+1)
5.08% less ownership
Funds ownership: 22.15% → 17.08% (-5.1%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
43% less capital invested
Capital invested by funds: $2.2M → $1.26M (-$944K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$15.5K |
| 2 |
HF
HRT Financial
New York
|
+$14.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$8.18K |
| 4 |
Renaissance Technologies
New York
|
+$5.93K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$304K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$130K |
| 3 |
Millennium Management
New York
|
-$61K |
| 4 |
BlackRock
New York
|
-$15K |
| 5 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$9.39K |
NEXI Hedge Fund Activity: Q2 2023 in Review
32 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2023, worth a combined $1.26M — down 43% from $2.2M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NEXI positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $15.5K. The largest seller was Citigroup, exiting entirely with an estimated $304K sold.
- 32 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2023, up from 31 in Q1 2023.
- Funds reported $1.26M of NexImmune, Inc. Common Stock stock for Q2 2023, down 43% quarter-over-quarter.
- 5 funds opened new NexImmune, Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of +1 holder.
- The largest NexImmune, Inc. Common Stock buyer in Q2 2023 was Jane Street, an estimated $15.5K added.
- The largest NexImmune, Inc. Common Stock seller in Q2 2023 was Citigroup, an estimated $304K sold.
Based on aggregated 13F filings for Q2 2023.